Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Associations of interleukin-1 gene cluster polymorphisms with C-reactive protein concentration and lung function decline in smoking-induced chronic obstructive pulmonary disease.

Wang Y, Shumansky K, Sin DD, Man SF, Akhabir L, Connett JE, Anthonisen NR, Paré PD, Sandford AJ, He JQ.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13125-35. eCollection 2015.

2.

NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease.

Sandford AJ, Malhotra D, Boezen HM, Siedlinski M, Postma DS, Wong V, Akhabir L, He JQ, Connett JE, Anthonisen NR, Paré PD, Biswal S.

Physiol Genomics. 2012 Aug 1;44(15):754-63. doi: 10.1152/physiolgenomics.00027.2012. Epub 2012 Jun 12.

3.

The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD).

Lee J, Sandford AJ, Connett JE, Yan J, Mui T, Li Y, Daley D, Anthonisen NR, Brooks-Wilson A, Man SF, Sin DD.

PLoS One. 2012;7(4):e35567. doi: 10.1371/journal.pone.0035567. Epub 2012 Apr 25.

4.

Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy.

Casaburi R, Porszasz J, Hecht A, Tiep B, Albert RK, Anthonisen NR, Bailey WC, Connett JE, Cooper JA Jr, Criner GJ, Curtis J, Dransfield M, Lazarus SC, Make B, Martinez FJ, McEvoy C, Niewoehner DE, Reilly JJ, Scanlon P, Scharf SM, Sciurba FC, Woodruff P; COPD Clinical Research Network.

COPD. 2012 Feb;9(1):3-11. doi: 10.3109/15412555.2011.630048.

PMID:
22292592
5.

Genetic association between human chitinases and lung function in COPD.

Aminuddin F, Akhabir L, Stefanowicz D, Paré PD, Connett JE, Anthonisen NR, Fahy JV, Seibold MA, Burchard EG, Eng C, Gulsvik A, Bakke P, Cho MH, Litonjua A, Lomas DA, Anderson WH, Beaty TH, Crapo JD, Silverman EK, Sandford AJ.

Hum Genet. 2012 Jul;131(7):1105-14. doi: 10.1007/s00439-011-1127-1. Epub 2011 Dec 28.

6.

Effect of heme oxygenase-1 polymorphisms on lung function and gene expression.

Tanaka G, Aminuddin F, Akhabir L, He JQ, Shumansky K, Connett JE, Anthonisen NR, Abboud RT, Paré PD, Sandford AJ.

BMC Med Genet. 2011 Sep 8;12:117. doi: 10.1186/1471-2350-12-117.

7.

Azithromycin for prevention of exacerbations of COPD.

Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR; COPD Clinical Research Network.

N Engl J Med. 2011 Aug 25;365(8):689-98. doi: 10.1056/NEJMoa1104623. Erratum in: N Engl J Med. 2012 Apr 5;366(14):1356.

8.

Effect of gene environment interactions on lung function and cardiovascular disease in COPD.

Hackett TL, Stefanowicz D, Aminuddin F, Sin DD, Connett JE, Anthonisen NR, Paré PD, Sandford AJ.

Int J Chron Obstruct Pulmon Dis. 2011;6:277-87. doi: 10.2147/COPD.S18279. Epub 2011 May 10.

9.

Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality.

Hill J, Heslop C, Man SF, Frohlich J, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD.

Eur Heart J. 2011 Aug;32(15):1918-25. doi: 10.1093/eurheartj/ehr124. Epub 2011 Jun 8.

PMID:
21653561
10.

Medication 'compliance' in asthma.

Anthonisen NR.

Can Respir J. 2011 Mar-Apr;18(2):68. English, French. No abstract available.

11.

Nontuberculous mycobacteria.

Anthonisen NR.

Can Respir J. 2011 Jan-Feb;18(1):9-10. English, French. No abstract available.

12.

'Tis the season.

Anthonisen NR.

Can Respir J. 2010 Nov-Dec;17(6):265-6. No abstract available.

13.

Garbage in, garbage out.

Anthonisen NR.

Can Respir J. 2010 Sep-Oct;17(5):211-2. English, French. No abstract available.

14.

Noninvasive ventilation.

Anthonisen NR.

Can Respir J. 2010 May-Jun;17(3):111-2. English, French. No abstract available.

15.

Geographical variations in the prevalence of atopic sensitization in six study sites across Canada.

Chan-Yeung M, Anthonisen NR, Becklake MR, Bowie D, Sonia Buist A, Dimich-Ward H, Ernst P, Sears MR, Siersted HC, Sweet L, Van Til L, Manfreda J.

Allergy. 2010 Nov;65(11):1404-13. doi: 10.1111/j.1398-9995.2010.02399.x.

PMID:
20557300
16.

Occupational asthma in detail.

Anthonisen NR.

Can Respir J. 2010 Mar-Apr;17(2):51-2. English, French. No abstract available.

17.

Asthma in the emergency room in Canada.

Anthonisen NR.

Can Respir J. 2010 Jan-Feb;17(1):13-4. English, French. No abstract available.

18.

Database epidemiology.

Anthonisen NR.

Can Respir J. 2009 Nov-Dec;16(6):181-2. English, French. No abstract available.

19.

Workers' compensation and mesothelioma.

Anthonisen NR.

Can Respir J. 2009 Sep-Oct;16(5):146-7. English, French. No abstract available.

20.

Retrospective studies.

Anthonisen NR.

Can Respir J. 2009 Jul-Aug;16(4):117-8. English, French. No abstract available.

21.

Vitamin D: the new panacea?

Anthonisen NR.

Can Respir J. 2009 May-Jun;16(3):73-4. English, French. No abstract available.

22.

Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.

Dransfield MT, Nahm MH, Han MK, Harnden S, Criner GJ, Martinez FJ, Scanlon PD, Woodruff PG, Washko GR, Connett JE, Anthonisen NR, Bailey WC; COPD Clinical Research Network.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):499-505. doi: 10.1164/rccm.200903-0488OC. Epub 2009 Jun 25.

23.

Efficient management of cough.

Anthonisen NR.

Can Respir J. 2009 Mar-Apr;16(2):41-2. English, French. No abstract available.

24.

Associations of IL6 polymorphisms with lung function decline and COPD.

He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, Connett JE, Anthonisen NR, Wise RA, Paré PD, Sandford AJ.

Thorax. 2009 Aug;64(8):698-704. doi: 10.1136/thx.2008.111278. Epub 2009 Apr 8.

25.

Efficacy of esomeprazole for treatment of poorly controlled asthma.

American Lung Association Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA.

N Engl J Med. 2009 Apr 9;360(15):1487-99. doi: 10.1056/NEJMoa0806290.

26.

Outpatient chronic obstructive pulmonary disease rehabilitation.

Anthonisen NR.

Can Respir J. 2009 Jan-Feb;16(1):9-10. English, French. No abstract available.

27.

Workplace asthma.

Anthonisen NR.

Can Respir J. 2008 Nov-Dec;15(8):402-3. English, French. No abstract available.

28.

Social factors and hospitallization.

Anthonisen NR.

Can Respir J. 2008 Oct;15(7):343-4. No abstract available.

29.

Chronic obstructive pulmonary disease in the emergency department.

Anthonisen NR.

Can Respir J. 2008 Sep;15(6):285-6. English, French. No abstract available.

30.

End-of-life care in chronic obstructive pulmonary disease.

Anthonisen NR.

Can Respir J. 2008 Jul-Aug;15(5):233-4. English, French. No abstract available.

31.

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?

Man SF, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Zhang X, Vessey R, Walker TG, Celli BR, Sin DD.

Eur Respir J. 2008 Dec;32(6):1451-7. doi: 10.1183/09031936.00153207. Epub 2008 Sep 17.

32.

Macrolide therapy in airways disease.

Anthonisen NR.

Can Respir J. 2008 May-Jun;15(4):177-8. No abstract available.

33.

Empyema.

Anthonisen NR.

Can Respir J. 2008 Mar;15(2):69-70. English, French. No abstract available.

34.

Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD.

He JQ, Shumansky K, Connett JE, Anthonisen NR, Paré PD, Sandford AJ.

Eur Respir J. 2008 Jul;32(1):25-34. doi: 10.1183/09031936.00040307. Epub 2008 Mar 19.

35.

Tiotropium and the treatment of chronic obstructive pulmonary disease.

Anthonisen NR.

Can Respir J. 2007 Nov-Dec;14(8):460-2. English, French. No abstract available.

36.

Chronic obstructive pulmonary disease.

Anthonisen NR.

Can Respir J. 2007 Oct;14(7):432-4. Review. No abstract available.

37.

Economic evaluations.

Anthonisen NR.

Can Respir J. 2007 Jul-Aug;14(5):264-6. Review. English, French. No abstract available.

38.

Airflow obstruction in young adults in Canada.

Al-Hazmi M, Wooldrage K, Anthonisen NR, Becklake MR, Bowie D, Chan-Yeung M, Dimich-Ward H, Ernst P, Manfreda J, Sears MR, Siersted HC, Sweet L, Van Til L.

Can Respir J. 2007 May-Jun;14(4):221-7.

39.

Chronic obstructive pulmonary disease and coronary artery bypass grafting.

Anthonisen NR.

Can Respir J. 2007 Jan-Feb;14(1):13-4. English, French. No abstract available.

40.

A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.

Soriano JB, Sin DD, Zhang X, Camp PG, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Petersson S, Postma DS, Szafranski W, Vestbo J.

Chest. 2007 Mar;131(3):682-689. doi: 10.1378/chest.06-1696.

PMID:
17356080
41.

Polymorphisms of interleukin-10 and its receptor and lung function in COPD.

He JQ, Shumansky K, Zhang X, Connett JE, Anthonisen NR, Sandford AJ.

Eur Respir J. 2007 Jun;29(6):1120-6. Epub 2007 Mar 1.

42.

[Whither spirometry?].

Anthonisen NR.

Can Respir J. 2006 Nov-Dec;13(8):411-2. English, French. No abstract available.

43.

Predicting episodes of poor asthma control in treated patients with asthma.

McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, Anthonisen NR; American Lung Association Asthma Clinical Research Centers.

J Allergy Clin Immunol. 2006 Dec;118(6):1226-33. Epub 2006 Oct 23.

PMID:
17157651
44.

Mortality in COPD: Role of comorbidities.

Sin DD, Anthonisen NR, Soriano JB, Agusti AG.

Eur Respir J. 2006 Dec;28(6):1245-57. Review.

45.

Action plans.

Anthonisen NR.

Can Respir J. 2006 Oct;13(7):357-8. No abstract available.

46.

"Susceptible" smokers?

Anthonisen NR.

Thorax. 2006 Nov;61(11):924-5. No abstract available.

47.

Transforming growth factor-beta1 polymorphisms, airway responsiveness and lung function decline in smokers.

Ogawa E, Ruan J, Connett JE, Anthonisen NR, Paré PD, Sandford AJ.

Respir Med. 2007 May;101(5):938-43. Epub 2006 Oct 27.

48.

Computed tomography scans of the thorax.

Anthonisen NR.

Can Respir J. 2006 Sep;13(6):301-2. No abstract available.

49.

Association of Hck genetic polymorphisms with gene expression and COPD.

Zhang X, Mahmudi-Azer S, Connett JE, Anthonisen NR, He JQ, Paré PD, Sandford AJ.

Hum Genet. 2007 Jan;120(5):681-90. Epub 2006 Sep 26.

PMID:
17024369
50.

Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers.

Tanaka G, Sandford AJ, Burkett K, Connett JE, Anthonisen NR, Paré PD, He JQ.

Eur Respir J. 2007 Jan;29(1):34-41. Epub 2006 Sep 13.

Supplemental Content

Loading ...
Support Center